Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ5F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,934
Award facts
- Contract value 100% obligated
- $24,934.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,934 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. The award represents a child contract with completion scheduled for February 10, 2026, and was made on a non-set-aside, competitive basis. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under Amerisourcebergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2031, which authorizes the supply of comprehensive pharmaceutical products and medical supplies globally.
SKYRIZI is a biologic medication used to treat autoimmune and inflammatory conditions, and this delivery order fulfills specific medical supply requirements for the Defense Health Agency and military treatment facilities. The delivery order demonstrates Amerisourcebergen's continued role as a prime pharmaceutical vendor within DLA's supply chain, leveraging its established IDC vehicle to provide specialized brand-name medications efficiently to support military healthcare operations. The non-set-aside award confirms the company's competitive capability to meet federal procurement requirements for specialized pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FJJ5F?
SPE2DR26FJJ5F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJJ5F worth?
The government has obligated $24,934 on SPE2DR26FJJ5F.
Is contract SPE2DR26FJJ5F an order under another contract?
Yes. SPE2DR26FJJ5F is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ5F competed?
The extent of competition for SPE2DR26FJJ5F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award